BACKGROUND: Patients with aneurysmal subarachnoid hemorrhage experience myocardial injury at the time of rupture, but its effect on functional recovery and disability is unclear. OBJECTIVE: To describe the prevalence of myocardial injury, as indicated by high serum levels of cardiac troponin I (≥0.3 ng/mL), within the first 5 days after aneurysmal subarachnoid hemorrhage and the effect of the injury on 3-month functional recovery and disability. METHODS: In a prospective longitudinal study, 239 patients with Hunt/Hess grade 3 or greater and/or Fisher grade 2 or greater at admission had serum level of troponin I measured on days 0 to 5. Patients were interviewed at 3 months to evaluate functional recovery (Glasgow Outcome Scale) and functional disability (Modified Rankin Scale). Statistics included χ² analysis, t tests, and binary logistic regression. RESULTS: Troponin values were elevated in 33.5% of the patients, and few patients in either group had a history of coronary artery disease (7.4% with troponin levels ≥0.3 ng/mL vs 2.7% with levels <0.3 ng/mL, P = .12). Higher troponin levels were significantly related to age and Hunt/Hess and Fisher grades, but not race, and were significantly associated with poorer functional recovery (P < .001) and more functional disability (P < .001). Even after controls for age, race, and more severe Hunt/Hess grades, higher levels remained a significant predictor of poorer functional recovery (P = .04) and disability (P = .01). CONCLUSION Elevated levels of cardiac troponin I after aneurysmal subarachnoid hemorrhage are common in patients with no cardiac history, are associated with severity of the hemorrhage, and are independently predictive of poorer functional recovery and increased disability.
BACKGROUND:Patients with aneurysmal subarachnoid hemorrhage experience myocardial injury at the time of rupture, but its effect on functional recovery and disability is unclear. OBJECTIVE: To describe the prevalence of myocardial injury, as indicated by high serum levels of cardiac troponin I (≥0.3 ng/mL), within the first 5 days after aneurysmal subarachnoid hemorrhage and the effect of the injury on 3-month functional recovery and disability. METHODS: In a prospective longitudinal study, 239 patients with Hunt/Hess grade 3 or greater and/or Fisher grade 2 or greater at admission had serum level of troponin I measured on days 0 to 5. Patients were interviewed at 3 months to evaluate functional recovery (Glasgow Outcome Scale) and functional disability (Modified Rankin Scale). Statistics included χ² analysis, t tests, and binary logistic regression. RESULTS: Troponin values were elevated in 33.5% of the patients, and few patients in either group had a history of coronary artery disease (7.4% with troponin levels ≥0.3 ng/mL vs 2.7% with levels <0.3 ng/mL, P = .12). Higher troponin levels were significantly related to age and Hunt/Hess and Fisher grades, but not race, and were significantly associated with poorer functional recovery (P < .001) and more functional disability (P < .001). Even after controls for age, race, and more severe Hunt/Hess grades, higher levels remained a significant predictor of poorer functional recovery (P = .04) and disability (P = .01). CONCLUSION Elevated levels of cardiac troponin I after aneurysmal subarachnoid hemorrhage are common in patients with no cardiac history, are associated with severity of the hemorrhage, and are independently predictive of poorer functional recovery and increased disability.
Authors: N Parekh; B Venkatesh; D Cross; A Leditschke; J Atherton; W Miles; A Winning; A Clague; C Rickard Journal: J Am Coll Cardiol Date: 2000-10 Impact factor: 24.094
Authors: J T Lindsay Wilson; Asha Hareendran; Marie Grant; Tracey Baird; Ursula G R Schulz; Keith W Muir; Ian Bone Journal: Stroke Date: 2002-09 Impact factor: 7.914
Authors: J Michael Frangiskakis; Marilyn Hravnak; Elizabeth A Crago; Masaki Tanabe; Kevin E Kip; John Gorcsan; Michael B Horowitz; Amin B Kassam; Barry London Journal: Neurocrit Care Date: 2009-01-28 Impact factor: 3.210
Authors: Poyee Tung; Alexander Kopelnik; Nader Banki; Ken Ong; Nerissa Ko; Michael T Lawton; Daryl Gress; Barbara Drew; Elyse Foster; William Parmley; Jonathan Zaroff Journal: Stroke Date: 2004-01-22 Impact factor: 7.914
Authors: Katherine M Duello; Jay P Nagel; Colleen S Thomas; Joseph L Blackshear; William D Freeman Journal: Neurocrit Care Date: 2015-08 Impact factor: 3.210
Authors: Amber McAteer; Marilyn Hravnak; Yuefang Chang; Elizabeth A Crago; Matthew J Gallek; Khalil M Yousef Journal: Biol Res Nurs Date: 2017-06-19 Impact factor: 2.522
Authors: Elizabeth Crago; Kelly Kerris; Chien-Wen J Kuo; Paula Sherwood; Marilyn Hravnak; David Crippen; Michael Horowitz Journal: Am J Crit Care Date: 2014-01 Impact factor: 2.228
Authors: Caron M Hong; Cigdem Tosun; David B Kurland; Volodymyr Gerzanich; David Schreibman; J Marc Simard Journal: Biomarkers Date: 2014-02-05 Impact factor: 2.658